Eritoran
- Generic Name
- Eritoran
- Drug Type
- Small Molecule
- Chemical Formula
- C66H126N2O19P2
- CAS Number
- 185955-34-4
- Unique Ingredient Identifier
- 551541VI0Y
Overview
Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.
Background
Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.
Indication
Investigated for use/treatment in sepsis and septicemia.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath